Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Does GEC1 Enhance Expression and Forward Trafficking of the Kappa Opioid Receptor (KOR) via Its Ability to Interact with NSF Directly?

Producción científica: Chapter › revisión exhaustiva

Resumen

We reported previously that GEC1 (glandular epithelial cell 1), a member of microtubule-associated proteins (MAPs), interacted directly with the C-tail of KOR (KCT) and tubulin and enhanced cell surface expression of KOR in CHO cells by facilitating its trafficking along the export pathway. Two GEC1 analogs (GABARAP and GATE16) were also shown to increase KOR expression. In addition, to understand the underlying mechanism, we demonstrated that N-ethylmaleimide-sensitive factor (NSF), an essential component for membrane fusion, co-immunoprecipitated with GEC1 from brain extracts. In this study, using pull-down techniques, we have found that (1) GEC1 interacts with NSF directly and prefers the ADP-bound NSF to the ATP-bound NSF; (2) D1 and/or D2 domain(s) of NSF interact with GEC1, but the N domain of NSF does not; (3) NSF does not interact with KCT directly, but forms a protein complex with KCT via GEC1; (4) NSF and/or α-SNAP do not affect KCT-GEC1 interaction. Thus, GEC1 (vs the α-SNAP/SNAREs complex) binds to NSF in distinctive ways in terms of the ADP- or ATP-bound form and domains of NSF involved. In conclusion, GEC1 may, via its direct interactions with KOR, NSF, and tubulin, enhance trafficking and fusion of KOR-containing vesicles selectively along the export pathway, which leads to increase in surface expression of KOR. GABARAP and GATE16 may enhance KOR expression in a similar way.

Idioma originalEnglish
Título de la publicación alojadaHandbook of Experimental Pharmacology
Páginas83-96
Número de páginas14
DOI
EstadoPublished - 2022

Serie de la publicación

NombreHandbook of Experimental Pharmacology
Volumen271
ISSN (versión impresa)0171-2004
ISSN (versión digital)1865-0325

Nota bibliográfica

Publisher Copyright:
© 2020, The Author(s), under exclusive license to Springer Nature Switzerland AG.

Financiación

Acknowledgements Supported by NIH grants R01 DA17302, R01 DA041359 and P30 DA13429 (LYLC), R01 NS046242 (SWW).

FinanciadoresNúmero del financiador
LYLCR01 NS046242
National Institutes of Health (NIH)R01 DA17302, R01 DA041359
Author National Institute on Drug Abuse DA031791 Mark J Ferris National Institute on Drug Abuse DA006634 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA026117 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA028162 Elizabeth G Pitts National Institute of General Medical Sciences GM102773 Elizabeth G Pitts Peter McManus Charitable Trust Mark J Ferris National Institute on Drug AbuseP30DA013429

    ASJC Scopus subject areas

    • Biochemistry
    • General Pharmacology, Toxicology and Pharmaceutics

    Huella

    Profundice en los temas de investigación de 'Does GEC1 Enhance Expression and Forward Trafficking of the Kappa Opioid Receptor (KOR) via Its Ability to Interact with NSF Directly?'. En conjunto forman una huella única.

    Citar esto